Prognostic markers for progression free survival (PFS) to anti PD-1 therapies in metastatic melanoma

Abstract

Peer reviewed

Umang Swami, Varun Monga, Tina Knutson, Aaron D. Bossler, Yousef Zakharia and Mohammed M. Milhem

Journal of clinical oncology, Vol.36(15_suppl), pp.e21527-e21527

05/20/2018

DOI: 10.1200/JCO.2018.36.15_suppl.e21527

View Online

Title: Subtitle: Prognostic markers for progression free survival (PFS) to anti PD-1 therapies in metastatic melanoma
Creators: Umang Swami - University of Iowa
Varun Monga - University of Iowa
Tina Knutson - University of Iowa Hospitals and Clinics
Aaron D. Bossler - University of Iowa
Yousef Zakharia - University of Iowa
Mohammed M. Milhem - University of Iowa
Resource Type: Abstract
Publication Details: Journal of clinical oncology, Vol.36(15_suppl), pp.e21527-e21527
DOI: 10.1200/JCO.2018.36.15_suppl.e21527
ISSN: 0732-183X
eISSN: 1527-7755
Language: English
Date published: 05/20/2018
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984363309402771

9 Record Views